Treatment & Services
- Gynecologic Surgical Pathology Slide Review
- Molecular Pathology
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.View All Plans
Education & Professional Highlights
Education & Fellowships
Fellowship - Johns Hopkins Hospital
Baltimore, MD USA
Fellowship - Barnes-Jewish Hospital/Washington University School of Medicine
St. Louis, MO USA
Residency - Cleveland Clinic
Cleveland, OH USA
Graduate School - Case Western Reserve University
Ph.D. Molecular Biology
Cleveland, OH USA
Medical Education - Zhengzhou University School of Medicine
- President of the Chinese American Pathologist Association (CAPA) 2007-2008
- President-elect of the Chinese American Pathologist Association 2006-2007
- Anatomic Pathology
- Anatomic Pathology - Cytopathology
- Pathology - Pathology Recertification
Cytopathology, Gynecologic pathology, fine needle aspiration, Molecular Pathology
Awards & Honors
- Patient Advocacy Award for promoting Pap tests and cervical cancer screening in under-served rural areas in China, from American Society of Cytopathology 2008
- ASC Research Seed Award from American Society of Cytopathology 2008
- Outstanding Achievement Award from Chinese American Pathologist Association 2008
- Geno Saccomanno New Frontiers in Cytology Award, from American Society of Cytopathology 2007 (only person who has received this prestigious award twice)
- Innovator Award for innovation in molecular cytopathology from Cleveland Clinic Foundation, 2006
- Hans Popper Research Award from American Society of Hepatopathology, 2003
- Young Investigator Award for excellence in Clinical Research from Johns Hopkins Medical Institutions, 2003
- Geno Saccomanno New Frontiers in Cytology Award from American Society of Cytopathology, 2002
- George Hoffman Award for excellent resident from Cleveland Clinic Foundation, Department of Pathology, 2000
- Resident Research Awards (First and Second Places) from Cleveland Society of Pathologists, 1999
- William E. Lower Clinical Research Award (Honorable Mention) from Cleveland Clinic Foundation, 1999
Innovations & Patents
- We have successfully filed a US patent with a title of "Detection of urothelial carcinoma in urine using DNA methylation profiling of tumor suppressor genes." (US utility patent #05136). Our study showed that using DNA methylation profiling, the sensitivity in detection of low grade bladder urothelial carcinoma is increased from 20% by cytomorphology alone to 85% using molecular approaches.
- United States and Canadian Academy of Pathology
- College of American Pathologists
- American Society of Investigative Pathology
- American Association of Cancer Research
- American Society of Cytopathology
Research & Publications
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 5/31/2019, Dr. Yang has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.